MedTrace Logo

The Influence of Passive Leg Elevation on the Cross-sectional Area of the Internal Jugular Vein in Infants or Young Children Undergoing Open Heart Surgery

NCT01401920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2013-12-25

No results posted yet for this study

Summary

The trendelenburg position is usually applied to increase the cross-sectional area of the IJV. However, trendelenburg position requires a tilt table to place the head in the down position. Trendelenburg position could also increase intracranial pressure. Passive leg elevation redistributes more blood from the lower extremity into the central veins and is proved to increase the cross-sectional area of IJV in adults. However, the effect of leg elevation on the cross-sectional area of IJV in small infants and children has not been evaluated.

The investigators evaluated the effect of passive leg elevation on the cross-sectional area of IJV in subjects undergoing open heart surgery for congenital anomaly.

Conditions

  • Infants or Children Undergoing Open Heart Surgery

Interventions

OTHER

leg elevation

bilateral passive leg elevation for 30 seconds

OTHER

Trendelenburg position

Trendelenburg position (15 degrees) for 30 seconds

OTHER

Trendelenburg position + passive leg elevation

Trendelenburg position + passive leg elevation

OTHER

control group

supine position without passive leg elevation or trendelenburg position

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Chung Su Kim, M.D.,Ph.D. · Samsung Medical Center

Eligibility

Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01401920 on ClinicalTrials.gov